Global Healthy Living Foundation to Integrate Walgreens Vaccine Scheduler, Enhancing Patient Access and Transparency The Global Healthy Living Foundation (GHLF) has announced a new collaboration with Walgreens aimed at simplifying…
Sapient Unveils Advanced Tumor Protein Mapping Platform to Decode Functional Biology Across Key Dimensions in Human Cancers Sapient, an emerging leader in multi-omics data generation and biomarker discovery, has unveiled…
Advancing Limb Salvage: Cagent Vascular Reports Landmark Peer-Reviewed Evidence Supporting Serration Remodeling Therapy™ in Complex Below-the-Ankle Arteries Cagent Vascular, a recognized innovator in endovascular device technologies, has announced the publication…
GSK Reports U.S. Food and Drug Administration Grants Breakthrough Therapy Designation and Priority Review Acceptance for Bepirovirsen in Chronic Hepatitis B as Potential First-in-Class Treatment Ionis Pharmaceuticals and its partner…
AIDS Healthcare Foundation Files Shareholder Proposal Urging Gilead Sciences to Increase Transparency on Patent Exclusivity Practices Access to life-saving medicines remains one of the most critical challenges in global healthcare,…
Mirai Bio to Debut Two Next-Generation Programs for Extrahepatic Targeted Nucleic Acid Delivery at the ASGCT 2026 Annual Meeting Mirai Bio, a company focused on enabling the next generation of…
Encoded Therapeutics to Present ETX101 Clinical Data in Dravet Syndrome at the 2026 ASGCT Presidential Symposium Encoded Therapeutics Inc. has announced its participation in the American Society of Gene &…
Dispatch Bio Showcases SEND-Based T Cell Armoring Approach at the ASGCT 2026 Annual Meeting Dispatch Bio has announced the presentation of new preclinical data highlighting its innovative SEND (Synthetic Efficacy…
QIAGEN Announces Preliminary Q1 2026 Results, Meets Adjusted EPS Outlook Amid Mixed Sales Performance and Revises Full-Year 2026 Guidance QIAGEN N.V. has released its preliminary financial results for the first…
Prothena Reports U.S. Food and Drug Administration Grants Fast Track Status to Coramitug (PRX004) for ATTR Cardiomyopathy, Secured by Novo Nordisk Prothena Corporation plc has announced a key regulatory development…
Janux Therapeutics Halts Development of JANX008 Program Janux Therapeutics, Inc. has announced its decision to discontinue further clinical development of JANX008, an investigational EGFR-targeted Tumor Activated T Cell Engager (TRACTr)…
Mundipharma Reports Positive Phase III ReSPECT Topline Results for ▼REZZAYO (rezafungin) in Preventing Invasive Fungal Diseases in Allogeneic Stem Cell Transplant Patients Mundipharma has announced encouraging topline results from its…